Securities,
Civil Litigation,
Corporate
Mar. 15, 2018
Theranos may face more legal trouble after SEC settlement
Theranos Inc., a Palo Alto blood test developer, and its CEO have agreed to settle “massive fraud” charges brought by the Securities and Exchange Commission, the agency announced on Wednesday.
"Massive fraud" charges are the latest legal battle for Palo Alto-based medical technology company Theranos Inc. and its CEO, according to an announcement on Wednesday from the Securities and Exchange Commission.
Theranos and its top executive have settled the charges.
The SEC filed two complaints in federal court in the Northern District on Wednesday, alleging Theranos, its founder and CEO Eliza...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In